Real clinical experience with alemtuzumab in patients with multiple sclerosis in Slovakia

被引：0

作者：

Kantorova, E. ^{[1
]}

Martinikova, M. ^{[2
]}

Kianickova, M. ^{[3
]}

Vitkova, M. ^{[4
]}

Kovacova, S. ^{[5
]}

Mako, M. ^{[6
]}

Hancinova, V. ^{[7
]}

Lisy, L. ^{[7
]}

Koleda, P. ^{[8
]}

Rohalova, J. ^{[8
]}

Poloniova, J. ^{[8
]}

Karlik, M. ^{[9
]}

Slezakova, D. ^{[9
]}

Klimova, E. ^{[9
]}

机构：

[1] Comenius Univ, Jessenius Fac Med Martin, Clin Neurol, Bratislava, Slovakia

[2] Fac Hosp Banska Bystr, Clin Neurol, Banska Bystrica, Slovakia

[3] Fac Hosp Trencin, Neurol, Trencin, Slovakia

[4] Univ PJ Safarik Kosice, Clin Neurol, Kosice, Slovakia

[5] Fac Hosp Nitra, Clin Neurol, Nitra, Slovakia

[6] Fac Hosp Trnava, Clin Neurol, Trnava, Slovakia

[7] Comenius Univ, Clin Neurol, Bratislava, Slovakia

[8] Mil Hosp Ruzomberok, Clin Neurol, Ruzomberok, Slovakia

[9] Comenius Univ, Clin Neurol, Bratislava, Slovakia

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPO-336

引用

页码：537 / 537

页数：1

共 50 条

[21] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
Zmira, Ofir
Halpern, Alex, I
Abraham, Lital
Achiron, Anat
ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1513 - 1518
[22] Alemtuzumab for multiple sclerosis
不详
LANCET, 2012, 380 (9856): : 1792 - 1792
[23] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
Ofir Zmira
Alex I. Halpern
Lital Abraham
Anat Achiron
Acta Neurologica Belgica, 2021, 121 : 1513 - 1518
[24] Alemtuzumab in Highly Active Multiple Sclerosis (HAMS): Experience with unlikely patients and unusual challenges
Krishnan, P.
Acharya, U.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP61 - NP61
[25] Lessons from clinical trials of alemtuzumab in multiple sclerosis
Chaudhuri, Abhijit
Behan, Peter O.
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (02) : 92 - 95
[26] Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects
Kousin-Ezewu, Onajite
Coles, Alasdair
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2013, 4 (03) : 97 - 103
[27] Alemtuzumab for multiple sclerosis
Riera, Rachel
Porfirio, Gustavo J. M.
Torloni, Maria R.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
[28] Alemtuzumab for Multiple Sclerosis
Mark D. Willis
Neil P. Robertson
Current Neurology and Neuroscience Reports, 2016, 16
[29] Alemtuzumab for multiple sclerosis
Riera, Rachel
Torloni, Maria Regina
Martimbianco, Ana Luiza C.
Pacheco, Rafael L.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
[30] Alemtuzumab in Multiple Sclerosis
Azzopardi, Laura
Coles, Alasdair
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 79 - 82

← 1 2 3 4 5 →